Synthesis of SM200
The Ru(II)-precursor 1 [6] and N-(2-pyridylmethyl) glycine 2 [7] were synthesized according to reported methods. Et 3 N was used without further purification and DMF was distilled over CaH 2 before usage. TLC plates for thin layer chromatography (silica gel 60 F 254 ) and silica gel for column chromatography (silica gel 60, 40-63 µm) were supplied by Merck KGaA.
1 H-NMR spectra were recorded using a Bruker Avance 300 (300 MHz), for IRspectra a Bruker Alpha-P FT-IR spectrometer and for mass spectra a LTQ-FT Ultra mass spectrometer from Thermo Fisher Scientific.
A 
Flow cytometry staining
Caspase-3 activated intracellular staining was achieved after cell fixation and permeabilization (BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution Kit), according to manufacturer's instructions. Cells were stained with primary Purified Rabbit anti-human caspase-3 activated antibody (Cell Signaling Technologies) diluted 1:200, 30 min at 4°C. This was followed by a secondary antibody incubation using anti-mouse Alexa488 (Life Technologies), 1:500 dilution, 20 min at 4°C. The percent of positive cells after SM200 treatment are reported after subtraction of background from the control staining. Samples were acquired with a Becton Dickinson LSRII 14 color flow cytometer and analyzed with FlowJo software (Tree Star Inc. Ashland, OR, USA). 
Supplementary
Compounds were tested on fibroblasts (control) and the melanoma cell lines 1205Lu, 451Lu, WM983B, and WM3918 over 72 h; effects were assessed using the MTS assay. 

